<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Treatment Timeline: CEA & MEDICINE 2022-2025</title>
    <style>
        * {
            box-sizing: border-box;
            margin: 0;
            padding: 0;
        }
        
        body {
            font-family: 'Segoe UI', Tahoma, Geneva, Verdana, sans-serif;
            background: linear-gradient(135deg, #f8f9fa, #e9ecef);
            color: #333;
            line-height: 1.6;
            padding: 20px;
            min-height: 100vh;
        }
        
        .container {
            max-width: 1400px;
            margin: 0 auto;
        }
        
        header {
            text-align: center;
            margin-bottom: 30px;
            padding: 20px;
            background: linear-gradient(to right, #2c3e50, #4a6582);
            color: white;
            border-radius: 12px;
            box-shadow: 0 4px 15px rgba(0,0,0,0.1);
        }
        
        header h1 {
            font-size: 2.2rem;
            margin-bottom: 10px;
        }
        
        header p {
            font-size: 1.1rem;
            opacity: 0.9;
        }
        
        .timeline {
            display: flex;
            flex-direction: column;
            gap: 30px;
        }
        
        .period {
            background: white;
            border-radius: 12px;
            overflow: hidden;
            box-shadow: 0 5px 20px rgba(0,0,0,0.08);
            transition: transform 0.3s ease;
        }
        
        .period:hover {
            transform: translateY(-5px);
        }
        
        .period-header {
            background: linear-gradient(to right, #3498db, #2c80b9);
            color: white;
            padding: 15px 20px;
            font-size: 1.3rem;
            font-weight: 600;
            display: flex;
            align-items: center;
        }
        
        .period-header::before {
            content: "";
            display: inline-block;
            width: 12px;
            height: 12px;
            background: white;
            border-radius: 50%;
            margin-right: 15px;
        }
        
        .table-container {
            overflow-x: auto;
            padding: 15px;
        }
        
        table {
            width: 100%;
            border-collapse: collapse;
            min-width: 600px;
        }
        
        th, td {
            border: 2px solid #dee2e6;
            padding: 14px 16px;
            text-align: center;
            font-size: 15px;
        }
        
        th {
            background-color: #e3f2fd;
            font-weight: 600;
            color: #1a237e;
            border-color: #bbdefb;
            position: sticky;
            top: 0;
        }
        
        .label-cell {
            background-color: #f8f9fa;
            font-weight: 600;
            color: #2c3e50;
            border-color: #dee2e6;
            text-align: left;
            min-width: 150px;
        }
        
        .cea-cell {
            background-color: #e8f5e9;
            font-weight: 900;
            border-color: #c8e6c9;
        }
        
        .med-cell {
            background-color: #fffde7;
            border-color: #ffecb3;
        }
        
        .med-cell-alt {
            background-color: #fff3e0;
            border-color: #ffe0b2;
        }
        
        .empty-cell {
            background-color: #f8f9fa;
        }
        
        .period-notes {
            padding: 15px 20px;
            background-color: #f8f9fa;
            border-top: 1px dashed #dee2e6;
            font-size: 0.95rem;
            color: #6c757d;
        }
        
        .legend {
            display: flex;
            justify-content: center;
            flex-wrap: wrap;
            gap: 20px;
            margin-top: 30px;
            padding: 20px;
            background: white;
            border-radius: 10px;
            box-shadow: 0 3px 10px rgba(0,0,0,0.08);
        }
        
        .legend-item {
            display: flex;
            align-items: center;
            gap: 8px;
        }
        
        .color-box {
            width: 20px;
            height: 20px;
            border-radius: 4px;
        }
        
        .cea-color {
            background-color: #e8f5e9;
            border: 2px solid #c8e6c9;
        }
        
        .med-color1 {
            background-color: #fffde7;
            border: 2px solid #ffecb3;
        }
        
        .med-color2 {
            background-color: #fff3e0;
            border: 2px solid #ffe0b2;
        }
        
        footer {
            text-align: center;
            margin-top: 40px;
            padding: 20px;
            color: #6c757d;
            font-size: 0.9rem;
        }
        
        @media (max-width: 768px) {
            header h1 {
                font-size: 1.8rem;
            }
            
            .period-header {
                font-size: 1.1rem;
            }
            
            th, td {
                padding: 10px 12px;
                font-size: 14px;
            }
        }
    </style>
</head>
<body>
    <div class="container">
        <header>
            <h1>CEA & MEDICINE Treatment Timeline</h1>
            <p>2022-05-25 â†’ 2025-05-29 with treatment cycles administered at 3-week intervals on average</p>
        </header>
        
        <div class="timeline">
            <!-- Period 1: 2022-06-04 to 2022-09-21 -->
            <div class="period">
                <div class="period-header">Treatment Period 1: June 2022 - September 2022</div>
                <div class="table-container">
                    <table>
                        <thead>
                            <tr>
                                <th class="label-cell">Test/Medication</th>
                                <th>2022-06-04</th>
                                <th>2022-08-19</th>
                                <th>2022-09-21</th>
                            </tr>
                        </thead>
                        <tbody>
                            <tr>
                                <td class="label-cell">CEA Level</td>
                                <td class="cea-cell">110</td>
                                <td class="cea-cell">81</td>
                                <td class="cea-cell">252.43</td>
                            </tr>
                            <tr>
                                <td class="label-cell">Medications</td>
                                <td class="med-cell">ELOXATIN=Oxaliplatin 150mg/20ml</td>
                                <td class="med-cell">AVASTIN=Bevacizumab</td>
                                <td class="med-cell">Nivolumab=OPDIVO 140mg</td>
                            </tr>
                            <tr>
                                <td class="label-cell"></td>
                                <td class="med-cell-alt">ERBITUX=Cetuximab</td>
                                <td class="med-cell-alt">Irinotecan HCL</td>
                                <td class="med-cell-alt">Ipilimumab=YERVOY 50mg</td>
                            </tr>
                            <tr>
                                <td class="label-cell"></td>
                                <td class="med-cell">Folinic Acid Leucovorin 300mg/30ml</td>
                                <td class="med-cell">Folinic Acid Leucovorin 300mg/30ml</td>
                                <td class="med-cell">Folinic Acid Leucovorin 300mg/30ml</td>
                            </tr>
                            <tr>
                                <td class="label-cell"></td>
                                <td class="med-cell-alt">FLUOROURACIL (5-FU)=EBEWE 500mg/10ml</td>
                                <td class="med-cell-alt">FLUOROURACIL (5-FU)=EBEWE 500mg/10ml</td>
                                <td class="med-cell-alt">FLUOROURACIL (5-FU)=EBEWE 500mg/10ml</td>
                            </tr>
                            <tr>
                                <td class="label-cell"></td>
                                <td class="empty-cell"></td>
                                <td class="empty-cell"></td>
                                <td class="med-cell">Docetaxel=TAXOTERE 80mg/2ml</td>
                            </tr>
                                                        <tr>
                                <td class="label-cell"></td>
                                <td class="empty-cell"></td>
                                <td class="empty-cell"></td>
                               <td class="med-cell">ELOXATIN=Oxaliplatin 150mg/20ml</td
                            </tr>
                        </tbody>
                    </table>
                </div>
                <div class="period-notes">
                    Initial treatment phase showing CEA level fluctuations and combination therapies
                </div>
            </div>
            
            <!-- Period 2: 2022-12-19 to 2023-07-14 -->
            <div class="period">
                <div class="period-header">Treatment Period 2: December 2022 - July 2023</div>
                <div class="table-container">
                    <table>
                        <thead>
                            <tr>
                                <th class="label-cell">Test/Medication</th>
                                <th>2022-12-19</th>
                                <th>2023-02-02</th>
                                <th>2023-07-14</th>
                            </tr>
                        </thead>
                        <tbody>
                            <tr>
                                <td class="label-cell">CEA Level</td>
                                <td class="cea-cell">27.27</td>
                                <td class="cea-cell">39.74</td>
                                <td class="cea-cell">7.92</td>
                            </tr>
                            <tr>
                                <td class="label-cell">Medications</td>
                                <td class="med-cell">Nivolumab=OPDIVO 140mg</td>
                                <td class="med-cell">Pembrolizumab=KEYTRUDA 100mg</td>
                                <td class="med-cell">Pembrolizumab=KEYTRUDA 100mg</td>
                            </tr>
                            <tr>
                                <td class="label-cell"></td>
                                <td class="med-cell-alt">Ipilimumab=YERVOY 50mg</td>
                                <td class="med-cell-alt">Ipilimumab=YERVOY 50mg</td>
                                <td class="med-cell-alt">Ipilimumab=YERVOY 50mg</td>
                            </tr>
                            <tr>
                                <td class="label-cell"></td>
                                <td class="med-cell">Folinic Acid Leucovorin 300mg/30ml</td>
                              <td class="empty-cell"></td>
                                <td class="empty-cell"></td>
                            </tr>
                            <tr>
                                <td class="label-cell"></td>
                                <td class="med-cell-alt">FLUOROURACIL (5-FU)=EBEWE 500mg/10ml</td>
                                <td class="empty-cell"></td>
                                <td class="empty-cell"></td>
                            </tr>
                            <tr>
                                <td class="label-cell"></td>
                                <td class="med-cell">Docetaxel=TAXOTERE 80mg/2ml</td>
                                <td class="empty-cell"></td>
                               <td class="empty-cell"></td>
                            </tr>
                                                        <tr>
                                <td class="label-cell"></td>
                              <td class="med-cell">ELOXATIN=Oxaliplatin 150mg/20ml</td>
                              <td class="empty-cell"></td>
                               <td class="empty-cell"></td>
                            </tr>
                        </tbody>
                    </table>
                </div>
                <div class="period-notes">
                    Continued treatment with notable decrease in CEA levels from previous period
                </div>
            </div>
            
            <!-- Period 3: 2023-10-12 to 2025-05-29 -->
            <div class="period">
                <div class="period-header">Treatment Period 3: October 2023 - May 2025</div>
                <div class="table-container">
                    <table>
                        <thead>
                            <tr>
                                <th class="label-cell">Test/Medication</th>
                                <th>2023-10-12</th>
                                <th>2024-11-15 Last Immunotherapy</th>
                                <th>2025-05-29</th>
                            </tr>
                        </thead>
                        <tbody>
                            <tr>
                                <td class="label-cell">CEA Level</td>
                                <td class="cea-cell">7.59</td>
                                <td class="cea-cell">17.8</td>
                                <td class="cea-cell">65</td>
                            </tr>
                            <tr>
                                <td class="label-cell">Medications</td>
                                <td class="med-cell">Pembrolizumab=KEYTRUDA 100mg</td>
                                <td class="med-cell">Pembrolizumab=KEYTRUDA 100mg</td>
                                <td class="empty-cell"></td>
                            </tr>
                            <tr>
                                <td class="label-cell"></td>
                                <td class="empty-cell"></td>
                                <td class="empty-cell"></td>
                                <td class="empty-cell"></td>
                            </tr>
                            <tr>
                                <td class="label-cell"></td>
                                <td class="empty-cell"></td>
                                <td class="empty-cell"></td>
                                <td class="empty-cell"></td>
                            </tr>
                            <tr>
                                <td class="label-cell"></td>
                                <td class="empty-cell"></td>
                                <td class="empty-cell"></td>
                                <td class="empty-cell"></td>
                            </tr>
                            <tr>
                                <td class="label-cell"></td>
                                <td class="empty-cell"></td>
                                <td class="empty-cell"></td>
                                <td class="empty-cell"></td>
                            </tr>
                        </tbody>
                    </table>
                </div>
                <div class="period-notes">
                    Final treatment phase with reduced medication regimen and 2023-10-12 CEA 7.59, the lowest rebounced to 2025-05-21 75
                </div>
            </div>
        </div>
        
        <div class="legend">
            <div class="legend-item">
                <div class="color-box cea-color"></div>
                <span>CEA Levels</span>
            </div>
            <div class="legend-item">
                <div class="color-box med-color1"></div>
                <span>Primary Medications</span>
            </div>
            <div class="legend-item">
                <div class="color-box med-color2"></div>
                <span>Supportive Medications</span>
            </div>
        </div>
        
        <footer>
            <p>Treatment Timeline Visualization | Data from 2022-05-25 to 2025-05-29</p>
            <p>Treatment cycles administered at 3-week intervals on average</p>Final treatment phase with reduced medication regimen and 2023-10-12 CEA 7.59, the lowest rebounced to 2025-05-21 75
        </footer>
    </div>
</body>
</html>